Monte Rosa Therapeutics GLUE - Cadena de opciones | ADVFN

US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Monte Rosa Therapeutics Inc (GLUE)
Monte Rosa Therapeutics Inc (GLUE) Opciones

Monte Rosa Therapeutics Inc (GLUE)

6.64

0.53

(8.67%)

Al cierre: 12 Marzo 2:00PM

Delayed by 15 minutes

6.64

-0.015

( -0.23% )

Fuera de horario: 3:25PM

Delayed by 15 minutes

GLUE Flujo de opciones

Calls

Strike	Compra	Venta	Ultimo Precio	P. Medio	Variación	Variación %	Volume	Int Abierto	Último Operado
2.50	3.70	6.00	0.00	4.85	0.00	0.00 %	0	0	-
5.00	1.25	4.00	0.00	2.625	0.00	0.00 %	0	0	-
7.50	0.40	0.40	0.40	0.40	0.00	0.00 %	0	42	-

Herramientas de nivel profesional para inversores individuales.

Puts

Strike	Compra	Venta	Ultimo Precio	P. Medio	Variación	Variación %	Volume	Int Abierto	Último Operado
2.50	0.05	0.05	0.05	0.05	0.00	0.00 %	0	10	-
5.00	0.05	0.80	0.15	0.425	0.00	0.00 %	0	12	-
7.50	0.65	1.50	2.00	1.075	0.00	0.00 %	0	4	-

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
DMNDamon Inc	US$ 0.2572 (43.93%)	9.2M
SGBXSafe and Green Holdings Corporation	US$ 0.721 (32.15%)	6.82M
INTWGraniteShares 2X Long INTC Daily ETF	US$ 24.40 (22.92%)	91.29k
VSTAVasta Platform Limited	US$ 3.97 (18.51%)	3.75k
RAILFreightCar America Inc	US$ 7.2999 (17.17%)	33.74k
CUTRCutera Inc	US$ 0.0412 (-57.48%)	11.42M
ADTXAditxt Inc	US$ 0.0312 (-45.07%)	49.79M
ULYUrgent ly Inc	US$ 0.3699 (-27.41%)	385.57k
HEPAHepion Pharmaceuticals Inc	US$ 0.039 (-20.08%)	18.93M
CMTLComtech Telecommunications Corporation	US$ 1.74 (-18.31%)	301.6k
ADTXAditxt Inc	US$ 0.0312 (-45.07%)	49.79M
INTCIntel Corporation	US$ 23.03 (11.36%)	21.59M
HEPAHepion Pharmaceuticals Inc	US$ 0.039 (-20.08%)	18.93M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.0345 (-11.54%)	14.23M
CUTRCutera Inc	US$ 0.0412 (-57.48%)	11.42M

Monksdream

Monksdream 3 meses hace

corncakes0

corncakes0 4 meses hace

Woodpecker3

Woodpecker3 4 meses hace

$GLUE investors have been in what Cramer calls "the house of pain" for months. Many purchased this at $40,$50,$60,$70 per share. The company will be added to the long list of biotech failures once the inevitable FDA trial failure is confirmed.

Woodpecker3

Woodpecker3 4 meses hace

$GLUE will soon be added to this list

https://www.fiercebiotech.com/special-reports/2023s-top-10-clinical-trial-flops

Woodpecker3

Woodpecker3 4 meses hace

$GLUE trapped alot of "investors" earlier this week at 10+ all the way to 12.50/Share. It is cratering just as precipitously. Watch for less than 8....7.....6... in days to come.

Woodpecker3

Woodpecker3 4 meses hace

$GLUE - No products. no revenues, massive losses, running out of cash. Millions of shares avaiable to short. Looking for $5/share

Monksdream

Monksdream 6 meses hace

Monksdream

Monksdream 6 meses hace

Monksdream

Monksdream 7 meses hace

Monksdream

Monksdream 8 meses hace

Monte Rosa Therapeutics

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones